Reverie Labs
Engineering next-generation, brain-penetrant cancer therapies.
What they do
Cancer therapies often fail to effectively treat tumors in the brain due to poor penetration across the blood-brain barrier.
The company engineers next-generation cancer therapeutics designed to be brain-penetrant.
Pharmaceutical companies and oncology drug developers seeking brain-penetrant cancer treatments.
Founders
General Partner @ YC Formerly CTO and Co-Founder at Reverie Labs. We started by building software for pharma companies to make better decisions with cutting-edge AI. We ended as a pharma company developing our own pipeline of assets using our ML tools. We sold Reverie to Ginkgo in February 2024. Previously AB/SM at Harvard in CS. I'm an ML research guy turned infra, full stack, data science, and everything in between.
Company timeline
- Founded2017
- YC batchWinter 2018
- StatusInactive
- Team size29 people
- LocationCambridge, MA, USA
Similar startups
